News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN)'s Dupilumab Successful In Phase 2 Study     9/30/2014
TONIX Pharmaceuticals, Inc. (TNXP)'s Pain Drug Fails Phase 2b Study     9/29/2014
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates     9/29/2014
FDA Says Novartis AG (NVS), Roche (RHHBY)'s Asthma Drug Xolair Raises Risk Of Heart, Brain Problems     9/29/2014
Pfizer (PFE)'s Lung Cancer Drug Xalkori Effective In Rare Gene Trial     9/29/2014
Merck & Co. (MRK)'s Keytruda Shows Positive Signs In Bladder Cancer Trial     9/29/2014
Merck & Co. (MRK)'s Keytruda Extends Immune System Fight To Stomach Cancer     9/29/2014
Hemispherx Biopharma (HEB) Expands Research On Potential Ebola Treatments To Five Independent Experts/Institutional Collaborators     9/29/2014
Novartis AG (NVS) Drug Afinitor Is First Treatment For Advanced Pancreatic NET To Provide Overall Survival Of More Than 3.5 Years In Phase 3 Trial     9/29/2014
Analysts Say Valeant Pharmaceuticals International (VRX)/Allergan Inc. (AGN) Deal Could Lead To Buying Spree     9/29/2014
Seattle Genetics, Inc. (SGEN), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Cancer Drug Meets Main Goal In Phase 3 Trial     9/29/2014
Boehringer Ingelheim Corporation's Afatinib Meets Primary Endpoint In Phase 3 Study Of Head And Neck Cancer     9/29/2014
Array BioPharma, Inc. (ARRY) Release: Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity     9/29/2014
Bristol-Myers Squibb Company (BMY)'s Immunotherapy Drug Opdivo Gets Six Month FDA Review For Melanoma     9/29/2014
Helsinn Group Release: Pivotal Phase 3 Trial Data For Anamorelin In ROMANA 1 And 2 Studies In Non-Small Cell Lung Cancer Patients With Anorexia-Cachexia Shows Significant Increase In Lean Body Mass, Body Weight And Improved Symptoms     9/29/2014

Featured Stories
Autistic Kids Are More Sedentary Than Their Peers, Oregon State University Study Shows     9/29/2014
Stress Might Be Even More Unhealthy For The Obese, Brandeis University Study     9/29/2014
Cells From Placentas Safe For Patients With Multiple Sclerosis, Mount Sinai School of Medicine Study     9/29/2014
Perfectionism Linked To Suicide: York University Psychology Expert     9/29/2014
Ebola - It's Far, Far Worse Than You Thought     9/26/2014
Brain Repair "May Be Boosted By Curry Spice," Institute Of Neuroscience And Medicine Study     9/26/2014
Can Diet Affect Multiple Sclerosis? Brigham and Women's Hospital Study     9/26/2014
Obesity Isn't Sole Cause Of Type 2 Diabetes, Maimonides Medical Center Study     9/26/2014
Exercise May Be Bad For Your Teeth, University Hospital Heidelberg Study     9/26/2014
Autism Risk May Increase If Gap Between Pregnancies Is Too Short Or Long, Columbia University And University of Turku Study     9/26/2014
Increasing Skirt Size Boosts Your Breast Cancer Risk, University College London Study     9/26/2014
Media Multitaskers Have Less Gray Matter, University Of Sussex Study     9/25/2014
Spouse’s Personality Influences Career Success, Washington University in St. Louis Study     9/25/2014
Working Long Hours Can Trigger Diabetes, University College London Study     9/25/2014
Eating Five A Day May Keep The Blues Away, University of Warwick Study     9/25/2014

More News
Bristol-Myers Squibb Company (BMY) Release: European Medicines Agency Validates The Marketing Authorization Application For Nivolumab In Non-Small Cell Lung Cancer     9/29/2014
Janssen Research & Development Release: ZYTIGA® Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer     9/29/2014
Keryx Biopharmaceuticals (KERX) Initiates Pivotal Phase 3 Study Of Ferric Citrate For The Treatment Of Iron Deficiency Anemia In Patients With Non-Dialysis Dependent Chronic Kidney Disease     9/29/2014
Agile Therapeutics, Inc. Announces Dosing Of First Patients In Twirla® Phase 3 SECURE Study     9/29/2014
Janssen Pharmaceutical Inc. Release: ZYTIGA®* Plus Prednisone Demonstrates Statistically Significant Overall Survival In Men With Advanced Prostate Cancer Prior To Chemotherapy     9/29/2014
Endocyte, Inc. (ECYT) Release: Phase 2b TARGET Trial Results Show Improved Survival In Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide     9/29/2014
CytRx Corporation (CYTR) Receives Multiple FDA Orphan Drug Designations For Aldoxorubicin For The Treatment Of Glioblastoma, Small Cell Lung Cancer And Ovarian Cancer     9/29/2014
Viralytics Ltd (VLA.AX) Release: Updated Positive Data From Phase 2 Trial Of CAVATAK In Late-Stage Melanoma     9/29/2014
Karyopharm Therapeutics (KPTI) Announces Clinical Data For Selinexor (KPT-330) In Advanced Solid Tumors     9/29/2014
Puma Biotechnology (PBYI) Announces Positive Initial Results From PB272 Phase II Trial In HER2 Mutated Non-Small Cell Lung Cancer     9/29/2014
Amarantus BioSciences, Inc. Requests Pre-IND Feedback From FDA For Eltoprazine Phase 2ib Parkinson's Disease Levodopa-Induced Dyskinesia Clinical Trial     9/29/2014
OncoMed Pharmaceuticals, Inc. (OMED)'s Demcizumab Phase 1b Clinical Trials Show Encouraging Safety And Anti-Tumor Activity At ESMO     9/29/2014
CEL-SCI (CVM) & U.S. Navy Administer Multikine To First Volunteer Patient In Phase I Clinical Trial For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients     9/29/2014
FDA Approves NeuroGenetic Pharmaceuticals, Inc. Application To Begin Clinical Trials For Its NGP 555 Compound To Treat And Prevent Alzheimer’s Disease     9/29/2014
Cancer Treatment Institute Of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination Of 3-Bromopyruvate And Salinomycin For Treatment Of Multiple Types Of Cancer     9/29/2014